Patents by Inventor Terese Soudah

Terese Soudah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9334219
    Abstract: The present invention provides a process for the preparation of a stable polymorph III of Atovaquone exhibiting characteristic peaks (expressed in degrees 20±0.2°?) at about 6.9, 9.6, 14.1, 14.7, 17.0, 18.5, 19.1, 19.9, 20.3, 22.0, 22.6, 23.2, 24.2, 26.8, and 28.5, which comprises: (a) providing a sample of Atovaquone particles; (b) heating the sample of Atovaquone particles at a minimal temperature of between 140° C. to 160° C. depending on the particle size of the sample; and (c) cooling the sample to obtain the stable polymorphic form of Atovaquone.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: May 10, 2016
    Assignee: TARO PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Wael Baidossi, Terese Soudah, Rosa Cyjon
  • Publication number: 20150307431
    Abstract: The present invention provides a process for the preparation of a stable polymorph III of Atovaquone exhibiting characteristic peaks (expressed in degrees 20±0.2°?) at about 6.9, 9.6, 14.1, 14.7, 17.0, 18.5, 19.1, 19.9, 20.3, 22.0, 22.6, 23.2, 24.2, 26.8, and 28.5, which comprises: (a) providing a sample of Atovaquone particles; (b) heating the sample of Atovaquone particles at a minimal temperature of between 140° C. to 160° C. depending on the particle size of the sample; and (c) cooling the sample to obtain the stable polymorphic form of Atovaquone.
    Type: Application
    Filed: December 17, 2014
    Publication date: October 29, 2015
    Applicant: TARO PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: WAEL BAIDOSSI, Terese Soudah, Rosa Cyjon
  • Publication number: 20140073816
    Abstract: The present invention provides a process for the preparation of a stable polymorph III of Atovaquone exhibiting characteristic peaks (expressed in degrees 2?±0.2°?) at about 6.9, 9.6, 14.1, 14.7, 17.0, 18.5, 19.1, 19.9, 20.3, 22.0, 22.6, 23.2, 24.2, 26.8, and 28.5, which comprises: (a) providing a sample of Atovaquone particles; (b) heating the sample of Atovaquone particles at a minimal temperature of between 140° C. to 160° C. depending on the particle size of the sample; and (c) cooling the sample to obtain the stable polymorphic form of Atovaquone.
    Type: Application
    Filed: March 14, 2012
    Publication date: March 13, 2014
    Applicant: TARO PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Wael Baidossi, Terese Soudah, Rosa Cyjon